Michael Carter, MD - Venture Partner

Focus: Biotechnology

Summary:
Dr. Michael Carter joined SVLS in 1998 as a Venture Partner. From 1986 to 1998 Michael was on the board of Zeneca Pharmaceuticals and from 1995 - 1998 was also a board member of Salick Healthcare - a US subsidiary of Zeneca.

Prior Experience:
Prior to that he was International Marketing Director at Zeneca Pharmaceuticals; in addition as International Medical Director he was involved in the clinical and commercial development of numerous medicines. For 10 years (1986 - 1996) he was a member of the UK Government's Medicines Commission. He has also worked at Roche Products as Director of the Pharmaceutical Division. Before entering the pharmaceutical industry, Michael practiced as a physician for eleven years. Michael is currently on the board of Fulcrum, GTx Inc, Micromet, and Santarus Inc, and was previously on the boards of CancerVax, Genosis, KuDOS and Warner Chilcott.

Qualifications:
Michael was trained as a physician and holds a BPharm from the London University School of Pharmacy. He is an elected Fellow of the Royal Pharmaceutical Society, the Royal College of Physicians of Edinburgh, and the Faculty of Pharmaceutical Medicine of the Royal College of Physicians.